Kainos Medicine, Inc. (XKON:A220250) announced a private placement of 310,077 common shares at an issue price of KRW 12,900 for gross proceeds of KRW 3,999,993,300 on July 30, 2019. The shares to be issued have a par value of KRW 500 per share. The transaction will involve participation from NH Investment & Securities Co., Ltd. (KOSE:A005940), and Gyounggi IBKC-STI New Job Creation Investment Fund.

The transaction has been approved by the board of directors of the company. The company will raise funds through third party allotment method. The securities issued will have a hold period of 1 year from the date of issuance.